Brochure
24 Aug 2026

Cell Line Development, Powered by Selexis

PDF 1.0 MB

Slow, unpredictable cell line development can cost you precious time, especially in early development, when timelines are tight and the pressure to deliver is high. KBI's Cell Line Development is made to flex, built to scale and proven to deliver. 

Content provided by our supplier

KBI Biopharma Inc.

  • Country/Region:
    United States
  • On CPHI since:
    2015
  • Employees:
    1000 - 4999
Company types
Biopharmaceutical company
CMO/CDMO
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Primary activities
Biopharmaceutical
Contract Manufacturer

Other Content from KBI Biopharma Inc. (11)